240 related articles for article (PubMed ID: 32885413)
1. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
Storelli F; Billington S; Kumar AR; Unadkat JD
Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
[TBL] [Abstract][Full Text] [Related]
2. Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.
Deo AK; Borson S; Link JM; Domino K; Eary JF; Ke B; Richards TL; Mankoff DA; Minoshima S; O'Sullivan F; Eyal S; Hsiao P; Maravilla K; Unadkat JD
J Nucl Med; 2014 Jul; 55(7):1106-11. PubMed ID: 24842892
[TBL] [Abstract][Full Text] [Related]
3. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
[TBL] [Abstract][Full Text] [Related]
4. An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter.
Kannan P; Schain M; Kretzschmar WW; Weidner L; Mitsios N; Gulyás B; Blom H; Gottesman MM; Innis RB; Hall MD; Mulder J
J Cereb Blood Flow Metab; 2017 Jun; 37(6):2062-2075. PubMed ID: 27488911
[TBL] [Abstract][Full Text] [Related]
5. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
Abuznait AH; Kaddoumi A
ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
[TBL] [Abstract][Full Text] [Related]
6. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
Biali ME; Auvity S; Cisternino S; Smirnova M; Hacker M; Zeitlinger M; Mairinger S; Tournier N; Bauer M; Langer O
Mol Pharm; 2023 Nov; 20(11):5877-5887. PubMed ID: 37883694
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-
Betterton RD; Abdullahi W; Williams EI; Lochhead JJ; Brzica H; Stanton J; Reddell E; Ogbonnaya C; Davis TP; Ronaldson PT
Drug Metab Dispos; 2022 Jul; 50(7):942-956. PubMed ID: 35504656
[TBL] [Abstract][Full Text] [Related]
8. Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.
Osgood D; Miller MC; Messier AA; Gonzalez L; Silverberg GD
Neurobiol Aging; 2017 Sep; 57():178-185. PubMed ID: 28654861
[TBL] [Abstract][Full Text] [Related]
9. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
10. Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET.
Zoufal V; Wanek T; Krohn M; Mairinger S; Filip T; Sauberer M; Stanek J; Pekar T; Bauer M; Pahnke J; Langer O
J Cereb Blood Flow Metab; 2020 Jan; 40(1):150-162. PubMed ID: 30354871
[TBL] [Abstract][Full Text] [Related]
11. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
[TBL] [Abstract][Full Text] [Related]
12. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
[TBL] [Abstract][Full Text] [Related]
13. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
14. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
Arduino I; Iacobazzi RM; Riganti C; Lopedota AA; Perrone MG; Lopalco A; Cutrignelli A; Cantore M; Laquintana V; Franco M; Colabufo NA; Luurtsema G; Contino M; Denora N
Int J Pharm; 2020 Dec; 591():120011. PubMed ID: 33115695
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
Harati R; Villégier AS; Banks WA; Mabondzo A
J Neuroinflammation; 2012 Dec; 9():273. PubMed ID: 23253775
[TBL] [Abstract][Full Text] [Related]
16. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
17. Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model.
Wanek T; Zoufal V; Brackhan M; Krohn M; Mairinger S; Filip T; Sauberer M; Stanek J; Pekar T; Pahnke J; Langer O
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153231
[TBL] [Abstract][Full Text] [Related]
18. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model.
Ding Y; Zhong Y; Baldeshwiler A; Abner EL; Bauer B; Hartz AMS
Fluids Barriers CNS; 2021 Mar; 18(1):10. PubMed ID: 33676539
[TBL] [Abstract][Full Text] [Related]
19. Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics.
Billington S; Salphati L; Hop CECA; Chu X; Evers R; Burdette D; Rowbottom C; Lai Y; Xiao G; Humphreys WG; Nguyen TB; Prasad B; Unadkat JD
Clin Pharmacol Ther; 2019 Jul; 106(1):228-237. PubMed ID: 30673124
[TBL] [Abstract][Full Text] [Related]
20. Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease.
Qosa H; Abuznait AH; Hill RA; Kaddoumi A
J Alzheimers Dis; 2012; 31(1):151-65. PubMed ID: 22504320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]